Carlsmed (NASDAQ: CARL) investors back board nominees and Ernst & Young
Rhea-AI Filing Summary
Carlsmed, Inc. held its 2026 Annual Meeting of Stockholders on June 3, 2026, where stockholders voted on director elections and auditor ratification. Niall Casey and Philip Young were elected as Class I directors to serve until the 2029 annual meeting or until successors are elected and qualified.
Casey received 19,627,716 votes for and 1,352,117 votes withheld, while Young received 19,510,686 votes for and 1,469,147 votes withheld, with 4,628,080 broker non-votes on each director proposal. Stockholders also ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 25,571,065 votes for, 5,858 against, and 30,990 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
independent registered public accounting firm financial
definitive proxy statement regulatory
Schedule 14A regulatory
emerging growth company regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.